Diffuse large B-cell lymphoma trials in Ukraine

4 trials · From ClinicalTrials.gov, checked 11 November 2026. Ask the study team whether a trial fits you.

• Phase 3Taking people
  A Study to Evaluate Zilovertamab Vedotin (MK-2140) Combination With Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (R-CHOP) in Participants With Previously Untreated DLBCL (MK-2140-010)

  Where

  Cherkasy, Ivano-Frankivsk, Khmelnytskiy, Kyiv, Lviv

  Age

  18 years and over

  People

  1,046 worldwide

  Run by

  Merck Sharp & Dohme LLC

  See details and how to joinNCT06717347 · EU 2024-515566-13-00
• Phase 2/3Taking people
  A Study of Zilovertamab Vedotin (MK-2140) in Combination With Standard of Care in Participants With Relapsed or Refractory Diffuse Large B-Cell Lymphoma (rrDLBCL) (MK-2140-003)

  Where

  Cherkasy, Ivano-Frankivsk, Kyiv, Lviv

  Age

  18 years and over

  People

  290 worldwide

  Run by

  Merck Sharp & Dohme LLC

  See details and how to joinNCT05139017 · EU 2022-502646-27-00
• Phase 1Taking people
  Dose Determining Study of EXS73565 in Participants With Relapsed or Refractory B-Cell Malignancies

  Where

  Kyiv

  Age

  18 years and over

  People

  85 worldwide

  Run by

  Exscientia AI Ltd., a wholly owned subsidiary of Recursion Pharmaceuticals, Inc.

  See details and how to joinNCT06980116 · EU 2024-516869-36-00
• Phase 1Taking people
  Study of SGR-1505 in Mature B-Cell Neoplasms

  Where

  Kyiv

  Age

  18 years and over

  People

  98 worldwide

  Run by

  Schrödinger, Inc.

  See details and how to joinNCT05544019 · EU 2023-505204-34-00